Cagrilintide + Semaglutide

Cagrilintide + Semaglutide is a research blend combining an amylin analogue with a GLP-1 receptor agonist, commonly studied in metabolic research involving satiety signalling, incretin pathways, glucose regulation and energy-balance mechanisms. Lianhua Peptide Co. — Hangzhou · Zhejiang · China — supplies Cagrilintide + Semaglutide for laboratory research with cGMP manufacturing standards, >98% purity specifications, HPLC-MS quality analysis, practical box ordering and tracked international fulfilment.

For laboratory and research use only. Not for human or animal consumption.